Low Immunotherapy Usage Seen Among Eligible Patients With Head and Neck, Thoracic Cancers in India dailynews.ascopubs.org/do/10.1200/ADN…

The first 3 questions I ask reading a cancer trial 1 Is the control arm the drug you would give your father if he were in your clinic? 2 Is the endpoint a fair measure of what matters to patients 3 Is post protocol treatment up to the standard of your clinic Consider... 🧵

Reason for rejection of a RCT manuscript done in India. Reviewer. 1. Reported survival is low (which is the reality). 2. Hi fi molecular testing not performed (expensive and not available). When will 10% of the world realize the reality of 90% of the world. #GlobalOncology

🚨RWD on Durva conso after CRT in stage III #NSCLC ➡️1006 pts, 31% completed 12mo Durva ➡️MC reason for dc progression 22%, iRAEs 15% ➡️Similar PFS for 9mo vs 12mo Durva ➡️Inf PFS for 6mo vs 12mo 💭Shorter durva=less cost=less AE 💭Need for prospective study OncoAlert #LCSM

Since my cancer diagnosis in 2017 (recurrence in 2021) I've had 3 surgeries, 12 organ resections, 2 stoma formations, 2 heated chemo treatments, 7 rounds oral chemo, 6 rounds IV chemo, several PEs & multiple bowel obstructions. I still have cancer but today I started a new job 😊

1/ 'There is a referred case for you', the ER doc tells me. 'How bad is it?' I ask him 'Pretty bad,' he says 'But nothing a good clinical history cant crack eh?', I tell him confidently 'That's the problem', he shoots back, ' the patient cant speak. He's on he ventilator'.

Online first: #Doxorubicin alone versus doxorubicin with #trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable #leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial thelancet.com/journals/lanon…

Metastatic TNBC: a Treatment Algorithm, just presented by Dr. Lisa Carey at #ESMO22 #bcsm #talktnbc #breastcancer

Day 1 #ESMO22 Highlights #CommunityOncology 1. #MONARCH3 in mBC 2. #TROPiCS02 in mBC Hope Rugo 3. Understanding HER-2Low Breast Ca Paolo Tarantino @prat_aleix 4. mTNBC in 2022 Lisa Carey, MD, ScM, FASCO 5. Management of RCC Elizabeth Plimack MD ESMO - Eur. Oncology #MedTwitter #OncEd #bcsm #GUSM 1/6

I like this paper very much: I believe this is the first treatment selection biomarker in the mHSPC selecting between NHT vs. Docetaxel OncoAlert Neeraj Agarwal, MD, FASCO Umang Swami, MD, MSCI, FASCO Clinical Cancer Research CONGRATS to the team ! @

That’s a fresh start! At ESMO Head n Neck preceptorship,Singapore ESMO - Eur. Oncology Head & Neck Connect Amrita Hospital, Kochi

Not everyday your fiercest rival on court is bawling his heart out at your retirement. What a great pair of sportspersons! True class. One of sports iconic rivalries finally ends. #FedalForever Roger Federer Rafa Nadal Respect 🙏

Approach to management of NSCLC #algorithm created by Matthew Ho and Aakash Desai, MD, MPH, FASCO giving 🔍into current Rx, credit National Comprehensive Cancer Network (NCCN) H. Jack West, MD, FASCO and resource for #patients, and #providers OncoAlert #MedTwitter #MedEd #Cancer #oncology PDF:drive.google.com/file/d/1iSX4uB…

Proud to share this, led by Dr (Prof). Vijay Patil and Dr. Kumar Prabhash. Effective low cost therapy accessible for almost all pts with #HNSCC. #HNCSM OncoAlert Tata Memorial Hospital TMH Medical Oncology Alumni Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study ascopubs.org/doi/abs/10.120…

New beginnings! New job.. Joined as Consultant Medical oncologist at Meitra Hospitals, Calicut, Kerala!

Yes. Dr (Prof). Vijay Patil is one of a kind. It is entirely our loss that we couldn't retain him. Academia will be poorer.

📢🥁By popular demand presenting the TOP Oncology publications of 2022. PS: List not exhaustive - so feel free to tag & add important papers to the list OncoAlert NEJM The Lancet Oncology Annals of Oncology Nature Medicine nature Cancer Discovery

Trastuzumab in HER2 positive BTC -getting there! ascopubs.org/doi/10.1200/JC… Dr Amol Akhade bhawna sirohi Tata Memorial Hospital Amol Patel Dr (Prof). Vijay Patil Vanita Noronha, MBBS MD DM South Asian Journal Of Cancer Ind J Med Ped Oncology TMH Medical Oncology Alumni Viraj Lavingia